Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-09-22 00:00:00 ET · period of report 2023-09-21 · accession 0001843568-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-22 | 2023-09-21 | MYGN | Ancona Margaret | SVP, Chief of Staff | A - Grant | $0.00 | +10.0K | 60.3K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-21 | A | A | 10,000 | $0.00 | 60,272 | D | — | — |